The Effect of Mobile Application-Assisted Nursing Services on Symptom Control in Breast Cancer Patients

Not Applicable

Not yet recruiting

• Conditions: Symptom Management; Quality of Life

• Registration Number: NCT07200791
• Lead Sponsor: Fenerbahce University

Brief Summary

Breast cancer is the most common type of cancer in women, accounting for approximately one-quarter of all female cancers in Turkey. Chemotherapy is widely used in treatment, but it also affects healthy cells, leading to numerous side effects such as fatigue, nausea, hair loss, sleep problems, and skin and nail changes. These side effects complicate symptom management and negatively impact patients' self-efficacy and quality of life.

Mobile health applications allow patients to track their symptoms, communicate with healthcare professionals, and implement recommended non-pharmacological methods. Literature demonstrates that these applications reduce symptoms, improve quality of life, and enhance self-efficacy.

This research is a randomized controlled experimental trial designed to evaluate the effect of mobile app-assisted nursing services on symptom management in women diagnosed with breast cancer and undergoing chemotherapy. The research will be conducted in the chemotherapy unit of a training and research hospital in Istanbul.

The study will consist of two groups: an intervention group and a control group. Randomization will be conducted using a computer-assisted method (random.org). Based on the power analysis, 74 patients will be included in the sample for 85% power at a 95% confidence interval, a significance level of p\<0.05, and a medium effect size.

Inclusion criteria include individuals aged 18 years and older, female, diagnosed with breast cancer, undergoing the 4AC-12 Paclitaxel protocol, owning and using a smartphone, and consenting to participate in the study. Exclusion criteria include patients with cardiac problems, liver or kidney failure, inability to use the mobile app, or providing incomplete data.

Study data will be collected online via a mobile app. The results of the study will demonstrate the effectiveness of mobile health apps in symptom management, increasing self-efficacy, and improving quality of life.

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-09
• Study First Submitted: 2025-09-23
• Study First Submitted QC: 2025-09-23
• Last Update Submitted: 2025-09-23
• Study First Posted: 2025-10-01
• Last Update Posted: 2025-10-01
• Study Start: 2025-12-01
• Primary Completion: 2026-04
• Study Completion: 2026-08-01

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: Female
• Target Recruitment: 74

Inclusion Criteria

• 18 yaş ve üzerinde olan,
• Çalışmaya katılmayı kabul eden,
• Meme kanseri tanısı alan kadınlar,
• 4AC-12 Paklitaksel tedavi protokolü uygulana,
• Okuma yazma bilen ve iletişim problemi olmayan,
• Akıllı telefonu olan bireyler
• Akıllı telefonu kullanabilen bireyler
• Verileri eksiksiz olarak dolduran bireyler

Exclusion Criteria

• Kardiyak problemi olan bireyler
• Karaciğer ve böbrek yetmezliği olan bireyler
• Mobil uygulama kullanamayan bireyler
• Akıllı telefon kullanamayan bireyler
• Araştırmadan ayrılmak isteyen bireyler
• Araştırmada çeşitli sebeplerle eksik veri toplanan bireyler

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change in Symptom Management Self-Efficacy	Baseline and 12 weeks after intervention	Measured by the Breast Cancer Chemotherapy Symptom Management Self-Efficacy Scale

Secondary Outcome Measures

Name	Time	Method
Change in Quality of Life	aseline and 12 weeks after intervention	Measured by the EORTC QLQ-BR23 Breast Cancer Module